R. Jeffrey Lewis, ExxonMobil Biomedical Sciences

Dr. R. Jeffrey Lewis is currently a Distinguished Scientific Associate in the Epidemiology, Health Surveillance and Quality Assurance Section of ExxonMobil Biomedical Sciences, Inc (EMBSI).  He is responsible for supporting ExxonMobil scientific programs related to naphthalene, 1,3-butadiene, human health risk assessment, regulatory affairs and regulatory impact analysis, and he is Chair of EMBSI’s Senior Technical Council.  

He has served on a number of industry trade association scientific committees (e.g., American Chemistry Council), external science advisory boards (e.g., the Alliance for Risk Assessment Expert Science Panel, U.S. Environmental Protection Agency Science Advisory Board for 1,3-butadiene) and is a member of the American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV) Committee.  Dr. Lewis also has  an adjunct faculty appointment at the University of Texas School of Public Health and is Past Treasurer for the Society for Risk Analysis.  

Dr. Lewis received his Bachelor of Science degree in biology from the University of Kansas and M.S. and Ph.D. degrees in Epidemiology from the University of Texas School of Public Health. In addition, he earned a Master of Business Administration degree from Rutgers University.